Skip to main content
 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$100,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Oregon

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 6

Issues related to enhanced cancer treatment and research; and issues related to health care access and health care coverage.

Issues related to biomedical research and nonhuman primates.

Issues related to the 340B Drug Pricing Program.

Issues related to Graduate Medical Education and federal student financial aid programs.

Fiscal 2027 appropriations related to federal research programs, health professions and nursing education workforce development and training and public health programs, including National Institutes of Health and HRSA Title VII and VIII funding.

Issues related to Medicare-Medicaid financing and policy.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem